McKinsey--right where you'd expect them: across the table from the Sacklers, getting us hooked on opioids

Here's a blurb from Medley 238.  My thanks to author Nat Eliason for alerting me to this analysis, even if the conclusion is well known.  Of course McKinsey was the prime advisor to the Sacklers while they were pushing oxycontin.  

How does McKinsey stay out of jail?  The law firms and CPA firms who advise criminals get nailed.  Remember Arthur Andersen?

Here's Eliason's summary, including his link to the original reporting.

    The World of Opiates

    💊 Another bombshell insight into how McKinsey helped Purdue "turbocharge" opiate sales came out last week. Apparently McKinsey suggested they give opiate distributors a rebate for every overdose attributable to the opiates. Don't worry if you kill anyone, you'll get your money back! 

➕ They were even kind enough to do the math for how much money this might mean: 

"The presentation estimated how many customers of companies including CVS and Anthem might overdose. It projected that in 2019, for example, 2,484 CVS customers would either have an overdose or develop an opioid use disorder. A rebate of $14,810 per “event” meant that Purdue would pay CVS $36.8 million that year."

🤐 I for one hope McKinsey gets wrapped into the legal proceedings. They're almost as to blame as Purdue is for the opiod epidemic considering they apparently helped convince Purdue to more aggressively market them: 

"Five years earlier, the documents show, they emailed colleagues about a meeting in which McKinsey persuaded the Sacklers to aggressively market OxyContin... The meeting “went very well — the room was filled with only family, including the elder statesman Dr. Raymond,” wrote Mr. Ghatak, referring to Purdue’s co-founder, the physician Raymond Sackler, who would die in 2017... “By the end of the meeting,” he wrote, “the findings were crystal clear to everyone and they gave a ringing endorsement of moving forward fast.”"